The E-health Application To Modify ORal Energy Intake and Measure Outcomes REmotely in ALS Clinical Trial (EAT MORE2)

The E-health Application To Modify ORal Energy Intake and Measure Outcomes REmotely in ALS Clinical Trial (EAT MORE2)

Publication date: Aug 09, 2019

This is phase IIa feasibility and tolerability study of a mobile health (mHealth) application designed to study the effects of remote dietary counseling on disease progression and quality of life. The study will consist of two phases: Part I will consist of building and beta-testing the ALS Nutrition app and Part II will consist of enrolling a larger cohort of users into the app.

Concepts Keywords
ALS RTT
ALS Association Amyotrophic lateral sclerosis
Android Enteral feeding
Beta Testing Neurological disorders
BMI Medicine
Cardiovascular Health
Clinical Trial Counseling
Cohort Myocardial infarction
Counseling Larger
Diabetes Clinical trial
Feeding Tube Feeding tube
Informed Consent ALS Association
IOS Android
Massachusetts General Hospital
MHealth
Myocardial Infarction
Neuron
Nutrition
Peripheral Vascular Disease
Phase IIa
Stroke
Tolerability
Weight Loss

Semantics

Type Source Name
disease DOID Motor Neuron Disease
disease MESH Motor Neuron Disease
gene UNIPROT ALG3
gene UNIPROT NR4A2
disease DOID peripheral vascular disease
disease MESH peripheral vascular disease
disease DOID myocardial infarction
disease MESH myocardial infarction
disease DOID stroke
disease MESH stroke
disease MESH cardiovascular disease
disease MESH weight loss
gene UNIPROT TUBE1
gene UNIPROT CTSB
drug DRUGBANK Methyltestosterone
disease MESH diagnosis
gene UNIPROT APP
disease MESH disease progression
gene UNIPROT IGFALS
disease DOID ALS

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *